Englander Institute for Precision Medicine

Inferring cancer progression from Single-Cell Sequencing while allowing mutation losses.

TitleInferring cancer progression from Single-Cell Sequencing while allowing mutation losses.
Publication TypeJournal Article
Year of Publication2021
AuthorsCiccolella S, Ricketts C, Gomez MSoto, Patterson M, Silverbush D, Bonizzoni P, Hajirasouliha I, Vedova GDella
JournalBioinformatics
Volume37
Issue3
Pagination326-333
Date Published2021 Apr 20
ISSN1367-4811
KeywordsAlgorithms, Humans, Mutation, Neoplasms, Phylogeny, Sequence Analysis, Single-Cell Analysis, Software
Abstract

MOTIVATION: In recent years, the well-known Infinite Sites Assumption has been a fundamental feature of computational methods devised for reconstructing tumor phylogenies and inferring cancer progressions. However, recent studies leveraging single-cell sequencing (SCS) techniques have shown evidence of the widespread recurrence and, especially, loss of mutations in several tumor samples. While there exist established computational methods that infer phylogenies with mutation losses, there remain some advancements to be made.

RESULTS: We present Simulated Annealing Single-Cell inference (SASC): a new and robust approach based on simulated annealing for the inference of cancer progression from SCS datasets. In particular, we introduce an extension of the model of evolution where mutations are only accumulated, by allowing also a limited amount of mutation loss in the evolutionary history of the tumor: the Dollo-k model. We demonstrate that SASC achieves high levels of accuracy when tested on both simulated and real datasets and in comparison with some other available methods.

AVAILABILITY AND IMPLEMENTATION: The SASC tool is open source and available at https://github.com/sciccolella/sasc.

SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

DOI10.1093/bioinformatics/btaa722
Alternate JournalBioinformatics
PubMed ID32805010
PubMed Central IDPMC8058767
Grant ListT32 GM083937 / GM / NIGMS NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021